OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Mesa on Mitigating Racial Disparities in MPN Clinical Trials

August 5th 2020

Ruben A. Mesa, MD, discusses mitigating racial disparities in myeloproliferative neoplasm clinical trials.

Dr. Maddocks on Treatment Considerations in Follicular Lymphoma

August 5th 2020

Kami J. Maddocks, MD, discusses treatment considerations for treatment selection in follicular lymphoma.

Dr. Gafita on Prognostic Models for Treatment With 177Lu-PSMA-617 in mCRPC

August 5th 2020

Andrei Gafita, MD, discusses key takeaways from a retrospective analysis evaluating lutetium-177 PSMA-617 in patients with metastatic castration-resistant prostate cancer.

Dr. Balzarotti on Questions With Consolidation and Maintenance Therapy in R/R DLBCL

August 5th 2020

Monica Balzarotti, MD, discusses remaining questions regarding consolidation and maintenance therapy in relapsed/refractory diffuse large B-cell lymphoma.

Dr. Palmer on the Treatment Landscape of aGVHD

August 4th 2020

Jeanne M. Palmer, MD, discusses the current treatment landscape of acute graft-versus-host disease.

Dr. Westin on Challenges With Precision Medicine in Endometrial Cancer

August 4th 2020

Shannon N. Westin, MD, MPH, discusses challenges with precision medicine in endometrial cancer.

Dr. Shore on Challenges with ADT in Recurrent Prostate Cancer

August 4th 2020

Neal D. Shore, MD, FACS, discusses challenges with androgen deprivation therapy in recurrent prostate cancer.

Dr. Al-Sawaf on New Safety Signals With Venetoclax/Obinutuzumab in the CLL14 Trial

August 4th 2020

Othman Al-Sawaf, MD, discusses new safety signals with venetoclax plus obinutuzumab in the phase 3 CLL14 trial.

Dr. Shum on Patient Consultation of Osimertinib in NSCLC

August 4th 2020

Elaine Shum, MD, discusses consulting patients with non-small cell lung cancer on the use of osimertinib.

Dr. Kumar on Treatment Discontinuation in the ENDURANCE Myeloma Trial

August 4th 2020

Shaji K. Kumar, MD, discusses treatment discontinuation in the phase 3 ENDURANCE trial in newly diagnosed multiple myeloma.

Dr. Soliman on the Rationale for Using Immunotherapy in TNBC

August 4th 2020

Hatem Soliman, MD, discusses the rationale for using immunotherapy in triple-negative breast cancer.

Dr. Agarwal on the Safety Profile of Olaparib in HRR Gene-Mutant mCRPC

August 4th 2020

Neeraj Agarwal, MD, discusses the safety profile of olaparib in homologous recombination repair gene-mutated metastatic castration-resistant prostate cancer.

Dr. Shaughnessy on Challenges With CAR T-Cell Therapy in Hematologic Malignancies

August 4th 2020

Paul J. Shaughnessy, MD, discusses challenges with CAR T-cell therapy in relapsed/refractory hematologic malignancies.

Dr. Wang on the Safety Profile of Brexucabtagene Autoleucel in Relapsed/Refractory MCL

August 3rd 2020

Michael Wang, MD, discusses the safety profile of the CAR T-cell therapy brexucabtagene autoleucel in relapsed/refractory mantle cell lymphoma.

Dr. Mirza on Final Data of the NSGO-AVANOVA2/ENGOT-OV24 Trial in Ovarian Cancer

August 3rd 2020

Mansoor Raza Mirza, MD, discusses the final survival analysis of the phase 3 NSGO-AVANOVA2/ENGOT-OV24 trial in recurrent, platinum-sensitive ovarian cancer.

Dr. Choueiri on Expanding the Therapeutic Armamentarium in mRCC

August 3rd 2020

Toni K. Choueiri, MD, discusses current and emerging treatment options for patients with metastatic renal cell carcinoma.

Dr. Gandara on the Impact of Immunotherapy on the Tumor Microenvironment in Lung Cancer

August 3rd 2020

David R. Gandara, MD, discusses the impact of immunotherapy on the tumor microenvironment in lung cancer.

Dr. Kundranda on the Need for Novel Treatments in Pancreatic Ductal Adenocarcinoma

August 3rd 2020

Madappa Kundranda, MD, PhD, discusses the need to develop novel treatments in pancreatic ductal adenocarcinoma.

Dr. Mesa on the Potential Utility of CAR T-Cell Therapy in MPNs

August 3rd 2020

Ruben A. Mesa, MD, discusses the potential utility of CAR T-cell therapy in myeloproliferative neoplasms.

Dr. Shore on Unique Challenges in Nonmetastatic CRPC

August 3rd 2020

Neal D. Shore, MD, FACS, discusses unique challenges in nonmetastatic castration-resistant prostate cancer.